You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ccx168

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Sumida City (CCX168, Placebo)

Completed
  • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
  • CCX168
  • Placebo
  • Sumida City, Tokyo, Japan
    Sumida Hospital, SOUSEIKAI Global Clinical Research Center
Aug 4, 2023

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168)

Completed
  • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
  • CCX168
  • Tempe, Arizona
    Celerion
Aug 4, 2023

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)

Completed
  • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
  • CCX168
  • +4 more
  • Tempe, Arizona
    Celerion
Aug 15, 2023

Vasculitis, Systemic Lupus Erythematosus (SLE) Trial in Allschwil (CCX168, Placebo)

Completed
  • Vasculitis
  • Systemic Lupus Erythematosus (SLE)
  • CCX168
  • Placebo
  • Allschwil, Switzerland
    Covance Clinical Research Unit (CRU) AG
Aug 2, 2023

Vasculitis Trial in Worldwide (Placebo, CCX168)

Completed
Has Results
  • Vasculitis
  • Placebo
  • CCX168
  • Feldkirch, Austria
  • +43 more
Jul 10, 2020

Atypical Hemolytic Uremic Syndrome Trial in Bergamo (CCX168)

Terminated
  • Atypical Hemolytic Uremic Syndrome
  • CCX168
  • Bergamo, Italy
    A.O. Papa Giovanni XXIII - U.O. Nefrologia e Dialisi/IRCCS IRFMN
Nov 13, 2017

Immunoglobulin A Nephropathy Trial in Sweden, United States (CCX168)

Completed
  • Immunoglobulin A Nephropathy
  • CCX168
  • Palo Alto, California
  • +5 more
Dec 19, 2016